Holen Sie sich die Stockscreener-App
642.35
1.22%
8.21
Regeneron Pharmaceuticals Inc Aktie (REGN) Neueste Nachrichten
TD Asset Management Inc. Acquires 29,322 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Royal London Asset Management Ltd. Purchases 409 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Advisors Asset Management Inc. Has $3.68 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by iA Global Asset Management Inc. - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS - MarketBeat
DCF Advisers LLC Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Why Pharma and Biotech Stocks Got Thrashed on Tuesday - The Motley Fool
Is Regeneron Pharmaceuticals, Inc. (REGN) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey
Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MSN
Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - The Manila Times
Regeneron Earnings Alert: Key Q1 2025 Results Coming April 29What to Watch - StockTitan
Regeneron stock touches 52-week low at $641.91 amid market shifts By Investing.com - Investing.com South Africa
Regeneron stock touches 52-week low at $641.91 amid market shifts - Investing.com
Regeneron's Franchise Tax Claims Require Trial, NY Judge Rules - Bloomberg Tax
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst? - Insider Monkey
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Corebridge Financial Inc. - MarketBeat
Vanguard Group Inc. Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Lawsuit Notice: Investors who hold Regeneron - GlobeNewswire
Magnetar Financial LLC Has $77.04 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
11 Best Extremely Profitable Stocks to Buy According to Analysts - Insider Monkey
Nerve Growth Factor Market: Analysis of Epidemiology, Pipeline - openPR
Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty - Benzinga
Simplify Asset Management Inc. Lowers Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Short Interest Update - MarketBeat
KLP Kapitalforvaltning AS Makes New $34.47 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
AXQ Capital LP Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Mizuho Securities USA LLC - MarketBeat
Xponance Inc. Has $11.59 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Vinva Investment Management Ltd Raises Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Harvest Fund Management Co. Ltd Buys 1,366 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Corient Private Wealth LLC Trims Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Forefront Wealth Management Inc. Acquires New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
American Century Companies Inc. Sells 30,949 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Virtu Financial LLC Has $3.06 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Summit Global Investments - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Teacher Retirement System of Texas - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Madison Investment Advisors LLC Makes New $4.59 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Avantax Advisory Services Inc. Boosts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Increased by Envestnet Portfolio Solutions Inc. - MarketBeat
Generali Asset Management SPA SGR Makes New $8.09 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Commonwealth Equity Services LLC Sells 967 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Nikko Asset Management Americas Inc. Sells 2,730 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Genmab, NHS England, Pistoia Alliance and Regeneron Win Bio-IT World Innovative Practices Awards - PR Newswire
First Week of November 21st Options Trading For Regeneron Pharmaceuticals (REGN) - Nasdaq
Blueshift Asset Management LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
3 Reasons to Sell REGN and 1 Stock to Buy Instead - Financial Content
Short Interest in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Increases By 16.8% - Defense World
Cibc World Markets Corp Grows Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Age-Related Macular Degeneration Therapeutics Market - openPR
Natixis Advisors LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Kazazian Asset Management LLC Invests $399,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Thrivent Financial for Lutherans Has $89.18 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Intact Investment Management Inc. Acquires Shares of 500 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
To Register Unwavering Growth Of Age-related Vision - openPR
Refractory Multiple Myeloma Treatment Market Size in 7MM - openPR
Greykasell Wealth Strategies Inc. Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Achmea Investment Management B.V. Reduces Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
3.14%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):